Effect of new anti-diabetic medications in combination with metformin compared to sulfonylurea in combination with metformin in patients with type 2 diabetes

dc.contributor.author	Desser, Arna S.
dc.contributor.author	Ringerike, Tove
dc.contributor.author	Klemp, Marianne
dc.date.accessioned	2018-01-16T19:13:12Z
dc.date.available	2018-01-16T19:13:12Z
dc.date.created	2015-01-09T13:10:08Z
dc.date.issued	2014
dc.identifier.isbn	978-82-8121-855-0
dc.identifier.uri	http://hdl.handle.net/11250/2477857
dc.language.iso	eng
dc.publisher	Norwegian Knowledge Centre for the Health Services
dc.relation.ispartof	Rapport fra Kunnskapssenteret
dc.relation.ispartofseries	Rapport fra Kunnskapssenteret
dc.subject.mesh	Diabetes Mellitus, Type 2
dc.subject.mesh	Metformin
dc.subject.mesh	Sulfonylurea Compounds
dc.subject.mesh	Dipeptidyl-Peptidase IV Inhibitors
dc.subject.mesh	Glucagon-Like Peptide 1
dc.subject.mesh	Drug Utilization
dc.title	Effect of new anti-diabetic medications in combination with metformin compared to sulfonylurea in combination with metformin in patients with type 2 diabetes
dc.type	Research report
dc.description.version	publishedVersion
dc.source.pagenumber	54
dc.source.volume	2014
dc.source.issue	9
dc.identifier.cristin	1194087
cristin.unitcode	7502,7,2,5
cristin.unitcode	7502,0,0,0
cristin.unitname	Legemidler og helseøkonomi
cristin.unitname	Folkehelseinstituttet
cristin.ispublished	true
cristin.fulltext	original